130 related articles for article (PubMed ID: 29391326)
1. Use of Proton Pump Inhibitors and risk of gastric cancer.
Karakan T
Turk J Gastroenterol; 2018 Jan; 29(1):143-144. PubMed ID: 29391326
[No Abstract] [Full Text] [Related]
2. Association between proton pump inhibitors therapy and the risk of gastric cancer.
Lai SW
Scand J Gastroenterol; 2019 Mar; 54(3):390. PubMed ID: 30856029
[No Abstract] [Full Text] [Related]
3. Proton pump inhibitors and risk for gastric cancer: Is it real?
Akriviadis E; Liava C
Turk J Gastroenterol; 2019 Mar; 30(3):309-310. PubMed ID: 30923034
[No Abstract] [Full Text] [Related]
4. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
Metz DC
Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors: Weighing the benefits and risks across various health conditions.
Sizgoric L; Likic R
Br J Clin Pharmacol; 2024 Feb; 90(2):388-391. PubMed ID: 38013514
[No Abstract] [Full Text] [Related]
6. Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man.
Waldum HL; Fossmark R
Gut; 2018 Jan; 67(1):199-200. PubMed ID: 29158236
[No Abstract] [Full Text] [Related]
7. Proton-pump inhibitors and increased gastric cancer risk: time-related biases.
Suissa S; Suissa A
Gut; 2018 Dec; 67(12):2228-2229. PubMed ID: 29298870
[No Abstract] [Full Text] [Related]
8. Barrett's esophagus: acid suppression, but no regression.
Bozymski EM; Shaheen NJ
Am J Gastroenterol; 1997 Apr; 92(4):556-8. PubMed ID: 9128299
[No Abstract] [Full Text] [Related]
9. [Comparative study of proton pump inhibitors].
Herszényi L; Tulassay Z
Orv Hetil; 2001 Sep; 142(36):1953-61. PubMed ID: 11680100
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of proton pump inhibitors and risks of gastric cancer.
Zeng R; Sha W; Wang J; Zhuo Z; Wu H; Leung FW; Chen H
Gut; 2022 Sep; 71(9):1924-1926. PubMed ID: 34836917
[No Abstract] [Full Text] [Related]
11. Proton pump inhibitors and risk of gastric cancer in a case-control study.
Lai SW; Lai HC; Lin CL; Liao KF
Gut; 2019 Apr; 68(4):765-767. PubMed ID: 29661803
[No Abstract] [Full Text] [Related]
12. Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer.
Yeo M; Kim DK; Park HJ; Cho SW; Cheong JY; Lee KJ
Cancer Sci; 2008 Jan; 99(1):185. PubMed ID: 18224727
[TBL] [Abstract][Full Text] [Related]
13. Acid control and regression of Barrett's esophagus: is the glass half full or half empty?
Castell DO; Katz PO
Am J Gastroenterol; 1997 Dec; 92(12):2329-30. PubMed ID: 9399786
[No Abstract] [Full Text] [Related]
14. [Proton pump inhibitors, a family of drugs in continuous expansion].
Pellicano R
Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085
[No Abstract] [Full Text] [Related]
15. [All proton pump inhibitors are equally efficacious in standard dosages].
Hellström PM; Vitols S
Lakartidningen; 2003 Jun; 100(25):2212-6. PubMed ID: 12872509
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors and gastric cancer: association is not causation.
Moayyedi P; Veldhuyzen van Zanten SJO; Hookey L; Armstrong D; Jones N; Leontiadis GI
Gut; 2019 Aug; 68(8):1529-1530. PubMed ID: 30006494
[No Abstract] [Full Text] [Related]
17. Thyroxine in goiter, H. pylori infection, and gastritis.
Dietrich JW; Boehm BO
N Engl J Med; 2006 Sep; 355(11):1177; author reply 1177. PubMed ID: 16971728
[No Abstract] [Full Text] [Related]
18. Synthesis or rupture: duration of acid inhibition by proton pump inhibitors.
Sachs G; Shin JM; Pratha V; Hogan D
Drugs Today (Barc); 2003 Mar; 39 Suppl A():11-4. PubMed ID: 12712216
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori: factors affecting eradication and recurrence.
Vakil N
Am J Gastroenterol; 2005 Nov; 100(11):2393-4. PubMed ID: 16279890
[TBL] [Abstract][Full Text] [Related]
20. Little necessity of acid inhibition against proton pump inhibitor rebound effects and prior helicobacter pylori eradication therapy in gastric ulcer patients: a randomized prospective study.
Wada Y; Ito M; Takata S; Kitamura S; Takamura A; Tatsugami M; Imagawa S; Matsumoto Y; Tanaka S; Yoshihara M; Chayama K
Hepatogastroenterology; 2009; 56(91-92):624-8. PubMed ID: 19621668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
